PICKER DONALD H
Chief Science Officer
PICKER DONALD H has filed 3 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Aug 5, 2026.
On the most recent filing, PICKER DONALD H is listed as Chief Science Officer at Moleculin Biotech, Inc. Inside the rolling window, PICKER DONALD H reported 1 open-market purchase in MBRX and no open-market sales.
Companies traded
Other insiders at MBRX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has PICKER DONALD H made?
PICKER DONALD H has filed 3 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does PICKER DONALD H trade?
PICKER DONALD H has filed SEC Form 4 disclosures for 1 company, including MBRX.
When was PICKER DONALD H's most recent SEC Form 4 filing?
PICKER DONALD H's most recent SEC Form 4 filing on Tracefour is dated Aug 5, 2026.
What is PICKER DONALD H's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, PICKER DONALD H is listed as Chief Science Officer.